Article
Substitutions of rtL228 and/or L229 are involved in the regulation of replication and HBsAg secretion in hepatitis B virus, and do not affect susceptibility to nucleos(t)ide analogs.
Molecular medicine reports - 1 Dec 2017
Qin Bo, Zhou Yechao, Zhou Guozhong, Xu Xiuping, Wang Yanan, Chen Jinkun
Abstract excerpt
Nucleos(t)ide analogs (NAs) are widely used in the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV). The mutation L210W of HIV‑1 reverse transcriptase (RT) is one of the six principal mutations which confer in vivo resistance to zidovudine. Due to the similar 3D‑structure and high conservation between HIV‑RT and HBV‑RT, the present study aimed to clarify whether corresponding mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.